Abstract:The metabolic syndrome is a constellation of metabolic disorders including obesity, hypertension, and insulin resistance, components which are risk factors for the development of diabetes, hypertension, cardiovascular, and renal disease. Pathophysiological abnormalities that contribute to the development of the metabolic syndrome include impaired mitochondrial oxidative phosphorylation and mitochondrial biogenesis, dampened insulin metabolic signaling, endothelial dysfunction, and associated myocardial functional abnormalities. Recent evidence suggests that impaired myocardial mitochondrial biogenesis, fatty acid metabolism, and antioxidant defense mechanisms lead to diminished cardiac substrate flexibility, decreased cardiac energetic efficiency, and diastolic dysfunction. In addition, enhanced activation of the renin–angiotensin–aldosterone system and associated increases in oxidative stress can lead to mitochondrial apoptosis and degradation, altered bioenergetics, and accumulation of lipids in the heart. In addition to impairments in metabolic signaling and oxidative stress, genetic and environmental factors, aging, and hyperglycemia all contribute to reduced mitochondrial biogenesis and mitochondrial dysfunction. These mitochondrial abnormalities can predispose a metabolic cardiomyopathy characterized by diastolic dysfunction. Mitochondrial dysfunction and resulting lipid accumulation in skeletal muscle, liver, and pancreas also impede insulin metabolic signaling and glucose metabolism, ultimately leading to a further increase in mitochondrial dysfunction. Interventions to improve mitochondrial function have been shown to correct insulin metabolic signaling and other metabolic and cardiovascular abnormalities. This review explores mechanisms of mitochondrial dysfunction with a focus on impaired oxidative phosphorylation and mitochondrial biogenesis in the pathophysiology of metabolic heart disease.

Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.

Role of Oxidative Stress in Diabetic Cardiomyopathy

Coordinated Contribution of NADPH Oxidase- and Mitochondria-Derived Reactive Oxygen Species in Metabolic Syndrome and Its Implication in Renal Dysfunction

Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases

Mitochondrial reactive oxygen species production and elimination

Mitochondrial-Endoplasmic Reticulum Communication-Mediated Oxidative Stress and Autophagy

Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease

Mitochondrial Biogenesis in the Metabolic Syndrome and Cardiovascular Disease

New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases

Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome

Mitochondrial Reactive Oxygen Species and Their Contribution in Chronic Kidney Disease Progression Through Oxidative Stress

Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease

Importance of Mitochondria in Cardiac Pathologies: Focus on Uncoupling Proteins and Monoamine Oxidases

Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy

Role of mitochondria in oxidative stress and aging

Oxidative stress in metabolic diseases: current scenario and therapeutic relevance

Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress

Mitochondrial network remodeling of the diabetic heart: implications to ischemia related cardiac dysfunction

Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy

Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease – an overview